Source link : https://newshealth.biz/health-news/fda-greenlights-novel-hypertension-pill-for-tough-to-treat-patients/
The FDA approved the first-in-class oral aldosterone synthase inhibitor baxdrostat (Baxfendy) to treat adults with uncontrolled hypertension in combination with other antihypertensive drugs, AstraZeneca announced. Aldosterone can raise blood pressure by stimulating retention of sodium and water and is a key contributor to persistently uncontrolled hypertension. Baxdrostat has high selectivity for aldosterone synthase, suppressing hormone […]
The post FDA Greenlights Novel Hypertension Pill for Tough-to-Treat Patients first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-18 19:25:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8